Today: 3 June 2026
Snap stock jumps in premarket after analyst upgrade as SNAP tries to rebound
10 February 2026
2 mins read

Snap stock jumps in premarket after analyst upgrade as SNAP tries to rebound

New York, Feb 10, 2026, 07:58 (EST) — Premarket.

Snap Inc (SNAP.N) shares jumped 3.7% to $5.38 ahead of the bell Tuesday, following Arete Research’s move to upgrade the stock to buy from neutral. Arete also lowered its price target to $7.30, down from $8.60. Pre-market trading takes place ahead of the U.S. market’s 9:30 a.m. ET open.

Snap’s still scraping along near its 52-week lows, even after the upgrade, with shares slashed by almost 50% over the past year. For short-term traders, that kind of backdrop can amplify any mood shift—a little optimism goes a long way when a stock’s already taken this much of a hit.

Snap shares slipped 0.6% to finish Monday at $5.19, after dipping to $5.09 earlier in the session. Roughly 93 million shares traded hands, according to price data. The stock’s been on a bumpy ride since last week’s earnings, as investors argue over whether the shakeout in advertising has run its course.

Snap topped revenue estimates for Q4 on Feb. 4, but its outlook for the first quarter fell short of what Wall Street had hoped for, citing stiff ad competition from bigger players like Meta’s Facebook and Instagram, along with TikTok. “The ads platform (of Snap) still has a long way to go in attracting big budgets from enterprise advertisers,” said Emarketer analyst Max Willens. Reuters

Snap rolled out a fresh stock buyback plan on Feb. 4, giving the green light for up to $500 million in repurchases over the next year. Shares could be bought on the open market or through private deals, the company said in its earnings report. CEO Evan Spiegel pointed to a focus on “profitable growth” as the driving force behind the latest results. Business Wire

Just a day after, Snap announced it had submitted its Form 10‑K for the year ending Dec. 31, 2025, putting audited financials up on the SEC’s site and its own investor relations page.

Wall Street isn’t budging much from its cautious stance. Analysts followed by Stock Analysis stick with a consensus “Hold” and set an average 12-month price target that sits notably higher than where shares trade now. That disconnect? For investors, it’s the possible upside if ad demand picks up — or a reminder that those targets could keep drifting lower if it doesn’t. StockAnalysis

Roth Capital Markets’ Rohit Kulkarni isn’t buying the dip just yet. He kept his neutral stance on Snap and dropped his price target to $7 from $10, describing the company’s first-quarter guidance as “uninspiring.” According to Cantech Letter, Kulkarni flagged sluggish progress on partnerships and weak momentum with major North American advertisers as potential drags on sentiment. Cantech Letter

U.S. risk sentiment faces its next challenge with incoming macro data that could jolt rate bets—and, in turn, shake up growth names tied to ad revenues. The Labor Department has the January Employment Situation report due Feb. 11, then inflation figures via the January CPI out Feb. 13. Traders have their eyes glued to both releases.

Latest articles

J-Star Stock Moves Up After Texas Battery Update in Pre-Market

J-Star Stock Moves Up After Texas Battery Update in Pre-Market

3 June 2026
J-Star Holding Co. surged to $1.36 in premarket trading after new disclosures on its proposed $122.5 million Baytown, Texas solid-state battery plant, pushing shares above Nasdaq’s $1 minimum less than a week before a key shareholder vote on a reverse split aimed at regaining compliance.
Legend Biotech jumps 42% as traders look at results from small cancer study

Legend Biotech jumps 42% as traders look at results from small cancer study

3 June 2026
Legend Biotech shares soared 42% to $36.28 after early Phase 1 data showed all six higher-dose patients with relapsed or refractory B-cell non-Hodgkin lymphoma responded to its in vivo CAR-T therapy LB2501, with five complete responses; UBS raised its price target to $49, citing the therapy’s outlook, but the results are early and based on a small group with short follow-up.
T1 Energy Stock Falls Premarket After $32M KORE Battery Deal

T1 Energy Stock Falls Premarket After $32M KORE Battery Deal

3 June 2026
T1 Energy shares fell 1.3% premarket after announcing a $32 million KORE Power acquisition to expand into battery storage and AI data-center infrastructure, just a day after a 15.7% stock surge; Northland initiated coverage with an outperform rating and $16 target, but flagged deal execution and funding as key risks.
UiPath Faces Three-Day Test for AI Stock Rebound

UiPath Shares Back in Focus After AI-Powered Earnings Jump; Eyes Stay on ARR

3 June 2026
UiPath shares retreated to $12.18 premarket after surging 12% on strong Q1 results and first-ever GAAP profitability, as Wall Street remains cautious amid rising competition and mixed analyst targets; investors now weigh if agentic AI adoption can sustain growth or if rivals will pressure recurring revenue.
Palo Alto Networks Reaches All-Time High Ahead of Results as AI Security Rally Drives Wall Street

Palo Alto shares fall premarket even after AI cyber earnings beat

3 June 2026
Palo Alto Networks shares fell in premarket trading to $290.88 despite raising full-year revenue and profit forecasts and posting a 31% jump in quarterly revenue to $3.0 billion, driven by AI-security demand and acquisitions, as investors weigh whether AI-driven growth is already priced in.
Bitcoin Price Clings to $70,000 After Rout as Bernstein Sticks With $150,000 Call
Previous Story

Bitcoin Price Clings to $70,000 After Rout as Bernstein Sticks With $150,000 Call

Natural gas price jolts the tape again as Williams stock rises on 2026 outlook
Next Story

Natural gas price jolts the tape again as Williams stock rises on 2026 outlook

Go toTop